Although others have found an inverse association between SRPK1 expression and cDDP or oxaliplatin sensitivity in retinoblastoma [42], our clinico-pathologic correlative studies did not show a relationship between cisplatin sensitivity and the level of SRPK1 expression in archived tumor samples. The gene discussed is SRPK1; the disease is neoplasm.